Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Advances in Coronary Angioplasty: Drug Eluting Stents' returned 53 results - Page 1 of 3   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Coronary Stents - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2011, Pages: 396 This report analyzes the worldwide markets for Coronary Stents in US$ Million and Thousand Units by the following Product Segments: Bare Metal Stents, and Drug Eluting Stents. The report provides Percutaneous Transluminal Coronary Angioplasty (PTCA) Products - Global Strategic Business Report   Global Industry Analysts, Inc., Sep 2011, Pages: 391 Interest 10 Drug-Eluting Balloons - A Threat to Drug-Eluting Stents in Coronary Procedures? 11 Safety Concerns on Drug Coronary Stents - Global Market Trends   Bizacumen Inc., Nov 2009, Pages: 141 Global DES Market 4 A 10-Year Outlook for the Coronary Stents Industry 5 3. MARKET TRENDS AND ISSUES 6 Drug Eluting Stent System - Safety Concerns 6 Drug Eluting Stent Market to Bounce Back 6 Drug-Eluting Stents - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 289 Abbott Launches Xience V Drug-Eluting Coronary Stent in Europe Boston Introduces Taxus(R) Express2(TM) in Japan Cordis Brings Advanced Drug-Eluting Stent Sorin Unveils Enhanced Janus Flex in Europe Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 363 SENSORS - INDUSTRY OVERVIEW TACHYCARDIA CARDIOPULMONARY (CPB) A DEVICE IDENTIFIES PATIENTS RISK B. CORONARY STENS CORONARY STENS – TYPES A. DRUG ELUTING STENTS (DES) B. BARE METAL STENTS (BMS) C Interventional Cardiology - Global Strategic Business Report   Global Industry Analysts, Inc., June 2010, Pages: 492 II-4 Table 3: World Coronary Stents Market (2006-2011): Percentage Breakdown of Value Sales by Stent Type for Bare-Metal Stents and Drug-eluting Stents (includes corresponding Global Coronary Stent Market Report: 2010 Edition   Koncept Analytics, Aug 2010, Pages: 36 bypass grafting or angioplasty (percutaneous coronary intervention) with or without stenting. The percutaneous coronary intervention procedures involving drug-eluting stents are being increasingly used Cardiovascular Drug Delivery - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 264 involved in gene therapy of cardiovascular disorders 5. Drug-Eluting Stents Introduction Percutaneous transluminal coronary angioplasty Stents Restenosis Pathomechanism Treatment Nitric oxide-based Global Interventional Cardiology Devices - Market Growth Analysis, 2009-2015   Axis Research Mind, Feb 2011, Pages: 647 CARDIOPULMONARY (CPB) A DEVICE IDENTIFIES PATIENTS RISK B. INTERVENTIONAL CARDIAC DEVICES CORONARY STENTING A. DRUG ELUTING STENTS (DES) B. BARE METAL STENTS (BMS) C. ABSORBABLE STENTS BACKGROUND PTCA BALLOON Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017   GlobalData, Dec 2011, Pages: 91 Major Cardiovascular Indications Approved for Drug Eluting Balloons 3.1 In-Stent Restenosis 3.1.1 Introduction 3.1.2 Pathophysiology 3.1.3 Etiology - Risk Factors 3.2 In-Stent Restenosis Epidemiology Intravascular Ultrasound (IVUS) - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2011, Pages: 200 Growth Revives as Drug Eluting Stents Bounce Back 34 Drug Eluting Stents Steal the Show 34 Drug Eluting Stent System - Safety Concerns 35 What's Next on Cards in Coronary Stents Market? 35 Major Innovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices   Business Insights, Aug 2007, Pages: 182 Ablative laser-assisted angioplasty Chapter 3 Emerging Coronary Stents and Stent Systems Summary Emerging Coronary Stents and Stent Systems Key Events Introduction of Drug-Eluting Stents (DES Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 390 by product types. The subdivisions are as: Interventional Cardiac Devices 1.Coronary Stents a.Drug Eluting Stents (DES) b.Bare Metal Stents (BMS) c.Absorbable Stents 2.PTCA Balloons a.FW Balloons b.Cable Wire Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016   GlobalData, April 2009, Pages: 56 Data Report Guidance 3 Major Cardiovascular Indications Approved for Drug Eluting Balloons (DEB): Disease Pathophysiology, Etiology, and Epidemiology 3.1 In-stent Restenosis 3.1.1 Introduction 3 Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 550 (CRT-D) SURGICAL ABLATION SURGICAL ABLATION OF ATRIAL FIBRILLATION A. CARDIAC ABLATION INTERVENTIONAL CARDIAC DEVICES CORONARY STENTING A. DRUG ELUTING STENTS (DES) B. BARE METAL STENTS (BMS) C Global Embolic Protection Devices (EPD) - Market Growth Analysis, 2009-2015   Axis Research Mind, Feb 2011, Pages: 509 : PROMOSING DEVICE OF CARDIACASSIST, INC EXCEEDS 1300 PROCEDURES ATRIUM MEDICAL’S “FIRST – IN-MAN” (FAM), DRUG ELUTING CLINICAL TRIAL USING CINATRA™ VOCLOSPORIN COATED CORONARY STENT SIEMEN’S ACUSON SC2000 Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 359 ’S “FIRST – IN-MAN” (FAM), DRUG ELUTING CLINICAL TRIAL USING CINATRA™ VOCLOSPORIN COATED CORONARY STENT SIEMEN’S ACUSON SC2000: THE REVOLUTION IN ECOCARDIOGRAPHY SIEMENS' NEW ULTRASOUND TRANSFORMS Electrocardiography (ECG) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 332 : PROMOSING DEVICE OF CARDIACASSIST, INC EXCEEDS 1300 PROCEDURES ATRIUM MEDICAL’S “FIRST – IN-MAN” (FAM), DRUG ELUTING CLINICAL TRIAL USING CINATRA™ VOCLOSPORIN COATED CORONARY STENT SIEMEN’S ACUSON SC2000 Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 396 GRAFT SIZE FOR CARDIOPASS EXTRA-AORTIC POST MARKET CLINICAL FOLLOW-UP (PMCF) ON PATIENTS FDA APPROVAL CLEARS THE WAY FOR BOSTON SCIENTIFIC’S PROMUS EVEROLIMUS – ELUTING CORONARY STENT SYSTEM ATS MEDICAL Diagnostic Electrophysiology Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015   Axis Research Mind, Feb 2011, Pages: 334 BY THE TANDEM HEART SYSTEM: PROMOSING DEVICE OF CARDIACASSIST, INC EXCEEDS 1300 PROCEDURES ATRIUM MEDICAL’S “FIRST – IN-MAN” (FAM), DRUG ELUTING CLINICAL TRIAL USING CINATRA™ VOCLOSPORIN COATED CORONARY STENT Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network